Pentraxin 3 concentration is associated with poor outcomes in patients with coronary artery disease: a systematic review and dose–response meta-analysis-Reference-Cited by-同舟云学术

Pentraxin 3 concentration is associated with poor outcomes in patients with coronary artery disease: a systematic review and dose–response meta-analysis

Published:2021-07-20 Issue: Volume: Page:1-10
ISSN:0001-5385
Container-title:Acta Cardiologica
language:en
Short-container-title:Acta Cardiologica

Author:

Kamarullah William¹^ORCID,Nurcahyani ²^ORCID,Multazam Rachmatu Bill³^ORCID,Josephine Claudia Mary³^ORCID

Affiliation:

1. Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia

2. Faculty of Medicine, University of Muhammadiyah Malang, Malang, Indonesia

3. Faculty of Medicine, Diponegoro University, Semarang, Indonesia

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2021.1948715

Reference37 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

2. WHO – Global burden of coronary artery disease [Internet]. Available from: https://www.who.int/cardiovascular_diseases/en/cvd_atlas_13_coronaryHD.pdf.

3. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction

4. Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease

5. C-Reactive Protein

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Dulaglutide on Serum Biomarkers of Atherosclerotic Plaque Instability: An Interventional Analysis of Cytokine Profiles in Diabetic Subjects—A Pilot Study;Medicina;2024-05-30

2. Pentraxin 3: A promising therapeutic target for cardiovascular diseases;Ageing Research Reviews;2024-01

3. Prediction of Progression of Coronary Atherosclerosis Using Molecular and Imaging Biomarkers;CardioMetabolic Syndrome Journal;2024

4. Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role;Biomedicine & Pharmacotherapy;2022-12

5. Treatment of Covid 19 Infection with Oselatamivir as First Line Antiviral Therapy for Non-Hospitalized Patients;Journal of Cardiology and Cardiovascular Research;2022-05-30